🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was intended to evaluate the efficacy, safety and tolerability o...
Status
Terminated
Location
Research Site
Start Date
2008-06
Trial ID
NCT00624468
Treatments Being Tested
This study is to evaluate the efficacy and safety of atacicept compared to ...
Status
Completed
Location
Division of Clinical Immunology and Rheumatology - UAB
Start Date
2008-01
Trial ID
NCT00624338
Treatments Being Tested
The purpose of this study is to learn whether atacicept treatment leads to ...
Status
Terminated
Location
Tulane University Hospital and Clinic Department of Internal Medicine
Start Date
2007-12
Trial ID
NCT00573157
Treatments Being Tested
To evaluate the safety and tolerability of atacicept and to explore if atac...
Status
Terminated
Location
Research Site
Start Date
2008-04
Trial ID
NCT00642902
Treatments Being Tested
A study to find how well atacicept works and how safe it is in participants...
Status
Recruiting
Location
Vera Therapeutics
Start Date
2025-07-07
Trial ID
NCT06983028
Treatments Being Tested
This is a multi-center, double-blind, randomized, Phase 2b trial to evaluat...
Status
Completed
Location
Pinnacle Research Group LLC
Start Date
2013-12
Trial ID
NCT01972568
Treatments Being Tested
This study (28851) is a long-term follow-up study of subjects enrolled in A...
Status
Terminated
Location
Research Site
Start Date
2009-03
Trial ID
NCT00853762
Treatments Being Tested
This is a multicenter, double-blind, Phase 2b, long-term extension (LTE) to...
Status
Terminated
Location
Pinnacle Research Group LLC
Start Date
2014-07-29
Trial ID
NCT02070978
Treatments Being Tested
The primary objective of this study is to evaluate the efficacy of atacicep...
Status
Completed
Location
Please Contact US Medical Information
Start Date
2007-09
Trial ID
NCT00595413
Treatments Being Tested
The sponsor electively terminated the study because the risk mitigation mea...
Status
Terminated
Location
EMD Serono Inc., One Technology Place
Start Date
2011-06
Trial ID
NCT01369628
Treatments Being Tested